HOME > RESOURCES > COMPANY PROFILES > NOVAVAX, INC.

Novavax, Inc. (NVAX)

Dr. Rahul Singhvi,

(484) 931-0150

Industry: Healthcare

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

News

Novavax Reports Positive Data For Its Trivalent Seasonal Influenza (VLP) Vaccine Candidate In A Second Phase II Study (PharmaceuticalOnline)

2009/11/03
RothmanResearch.com Equity Review for PWE, GNA, RX, TMR, GSS and NVAX (Marketwire)

2009/11/06
Crocs, Taser: Early Volume Movers (TheStreet.com)

2009/11/06

Visit our partner sites

Get Local News From bizjournals:

Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions. Company fundamental data provided by Hemscott. Economic data provided by Econoday. News provided by Comtex. Sec Filings data provided by Edgars. The Wall Street Horizon National Consumer Interest Rate Survey. ©2009 Wall Street Horizon. PMMS Mortgage Data ©2009 Freddie Mac. Mortgage averages are for conforming mortgages with 20% down.

Novavax, Inc. (NVAX)

News

Visit our partner sites

BizJournals

Get Local News From bizjournals:

Visit Condé Nast Digital sites: